Thus, canonical Wnt signaling inhibitors, such as sclerostin and DKK-1, are presumably negative regulators of AS; indeed, in several studies, serum sclerostin was significantly increased in chronic kidney disease patients with intensive vascular calcification [12]. This evidence concerns the gene SOST and chronic kidney disease.